Genetic Variants in EGFR/PLCE1 Pathway Are Associated with Prognosis of Esophageal Squamous Cell Carcinoma after Radical Resection

Abstract

Esophageal cancer (EC) is one of the most deadly malignant diseases. Several studies revealed that variations of the phospholipase C epsilon 1 (PLCE1) gene were associated with EC susceptibility. PLCE1 is located downstream of the epidermal growth factor receptor (EGFR) pathway. Presently, the single nucleotide polymorphisms (SNPs) of EGFR/PLCE1 genes and their associations with EC survival remain unclear. In this study, the associations between genetic variants in the EGFR/PLCE1 pathway and prognosis in 124 esophageal squamous cell carcinoma (ESCC) patients with radical resection were explored. The results showed that CC genotype of both PLCE1 rs17109671 and EGFR rs2072454 was associated with ESCC prognosis. Multivariate analysis revealed that patients with the two unfavorable genotypes had the worst overall survival (OS) or disease-free survival (DFS) (HR=6.099, 95%CI=1.903–19.552; HR=3.994, 95%CI=1.49–10.702, respectively). Additionally, combination of SNPs and tumor stage could better predict OS (for AUC, 0.774 vs. 0.709) and PFS (for AUC, 0.773 vs. 0.704) than tumor stage alone. In conclusion, genetic variants of the EGFR/PLCE1 may be predictors of the prognosis of ESCC after surgery. The individuals with the CC genotype of PLCE1 rs17109671 and EGFR rs2072454 should receive more aggressive treatments.

Keywords

esophageal squamous cell carcinoma / prognosis / single nucleotide polymorphism / survival / epidermal growth factor receptor

References

[1] TorreLA, BrayF, SiegelRL, et al.. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 652: 87-108

[2] FerlayJ, SoerjomataramI, DikshitR, et al.. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5): E359

[3] AllemaniC, WeirHK, CarreiraH, et al.. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet, 2015, 385(9972): 977-1010

[4] ChenWQ, ZhengRS, ZengHM, et al.. The incidence and mortality of major cancers in China, 2012. Chin J Can (Chinese), 2016, 35(73): 1-5

[5] ZengHM, ZhengRS, GuoYM, et al.. Cancer survival in China, 2003–2005: A population-based study. Int J Cancer, 2015, 136(8): 1921-1930

[6] DonohoeCL, ReynoldsJV, LysaghtJ, et al.. Neoadjuvant treatment of locally advanced esophageal and junctional cancer: the evidence-base, current key questions and clinical trials. J Thorac Dis, 2017, 9(8): 697-702

[7] CoxSJ, SeanMO, ColesB, et al.. Update on neoadjuvant regimens for patients with operable oesophageal/ gastrooesophageal junction adenocarcinomas and sq-uamous cell carcinomas. Curr Oncol Rep, 2017, 19(1): 7-18

[8] BrayF, FerlayJ, SoerjomataramI, et al.. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424

[9] LiWQ, HuN, BurtonV, et al.. PLCE1 mRNA and protein expression and survival of patients with esophageal squamous cell carcinoma and gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev, 2014, 23(8): 1579-1588

[10] AbnetCC, FreedmanND, HuN, et al.. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet, 2010, 42(9): 764-768

[11] NormannoN, TejparS, MorgilloF, et al.. Implications for KRAS status and EGFR-targeted therapies in metastatic CRC. Clin Oncol, 2009, 6(9): 519-527

[12] LinG, SunXJ, HanQB, et al.. Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma. Oncol Lett, 2015, 10(2): 901-906

[13] HuangJ, FanQG, LuP, et al.. Icotinib in patients with pretreated advanced esophageal squamous cell carcinoma with EGFR overexpression or EGFR gene amplification: a single-arm, multicenter phase 2 study. J Thorac Oncol, 2016, 11(6): 910-917

[14] JiaW, WangW, JiCS, et al.. Coexpression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance. Onco Targets Ther, 2016, 9: 5133-5142

[15] LiaoXW, HanCY, QinW, et al.. Genome-wide association study identified PLCE1-rs2797992 and EGFR-rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in Guangxi. Am J Transl Res, 2016, 8(4): 1799-1812

[16] BunneyTD, KatanM. Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer, 2010, 10(5): 342-352

[17] GressetA, SondekJ, KendallH, et al.. The Phospholipase C Isozymes and Their Regulation, in Phosphoinositides I: Enzymes of Synthesis and Degradation. Springer, 2012, 6(3): 61-94

[18] DusabanSS, PurcellNH, RockensteinE, et al.. Phospholipase Ce links G protein-coupled receptor activation to inflammatory astrocytic responses carcinoma. PNAS, 2013, 110(9): 3609-3614

[19] WingMR, BourdonDM, HardenTK, et al.. PLC-epsilon: a shared effector protein in Ras-, Rho-, and G alpha beta gamma-mediated signaling. Mol Interv, 2003, 3(5): 273-280

[20] WuC, HuZ, HeZ, et al.. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet, 2011, 43(7): 679-684

[21] WangLD, ZhouFY, LiXM, et al.. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1. Nat Genet, 2010, 42(9): 759-763

[22] CuiXB, ChenYZ, PangXL, et al.. Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population. Gene, 2013, 530(2): 315-322

[23] ZhaiSC, LiuC, ZhangLC, et al.. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail. Neoplasia, 2017, 19(3): 154-164

[24] HanN, ZhaoWC, ZhangZM, et al.. MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1. Biochem Biophys Res Commun, 2016, 470(1): 175-180

[25] CuiXB, LiS, LiTT, et al.. Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma. Oncotarget, 2015, 7(2): 1777-1795

[26] ZhouMR, LiY, WangN, et al.. Phospholipase C ε-1 gene polymorphisms and prognosis of esophageal cancer patients from a high-incidence region in northern China. Mol Clin Oncol, 2018, 8(1): 170

[27] ShiYY, YuanYG, XuZ, et al.. Genetic variation in the calcium/calmodulin-dependent protein kinase(CaMK) pathway is associated with antidepressant response in females. J Affect Disord, 2012, 136(3): 558

[28] NicholsonRI, GeeJMW, HarperME, et al.. EGFR and cancer prognosis. Eur J Cancer, 2001, 37: 9-15

[29] ZhangJF, ZhanZ, WuJ, et al.. Association among polymorphisms in EGFR gene exons, lifestyle and risk of gastric cancer with gender differences in Chinese Han subjects. PLoS One, 2013, 8(3): e59254